82.Issue 12 december 24 - INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES

Volume : 11, Issue : 12, December – 2024

Title:

MULTIDISCIPLINARY APPROACH BETWEEN EMERGENCY – NURSE – PHYSIOTHERAPY AND MEDICINE FOR DIABETES MANAGEMENT AND THE KEYS TO PREVENTING LONG-TERM CONSEQUENCES AND COMPLICATIONS

Authors :

Abdulaziz Ahmed M Alqahtani*, Ahmed Hamzah Bukhari, Abdulrahim Ali Alghamdi, Mohammed Abdulghani Sindi, Sagr Abdullah Aldawsari, Adel Obaidallah Aloufi, Ayed Salem Alghamdi, Hani Ruddah Alsufyani, Mohammed Mihmas Albaqami, Doaa Mahmoud Johari, Wed Ziyad Alnajjar, Roqayah Ibrahim Bellou, Hadeel Mohammed Mahjoob, Elham Hamid Ghabashi

Abstract :

Background: Diabetes Mellitus is a chronic disease that affects 200 million worldwide. Given the long-term systemic effects of the disease, it is essential to develop a management approach for diabetes to decrease its long-term complications along with the economic burden on patients. Objective: to establish a multidisciplinary approach to the management of diabetes and the comorbidities associated with it. Materials and methods: This review is a comprehensive search of PUBMED and medical literature from the year 2014 to 2024. Conclusion Diabetes is an ailment with multisystemic consequences that significantly affect the morbidity and mortality of the patient. Hence it is essential to assess and establish a comprehensive methodology to manage the disease that targets not only glycemic control, but the complications associated with it.
Keywords : Diabetes Mellitus; Diagnoses, Clinical Features, Management; Complications; Prevention

Cite This Article:

Please cite this article in press Abdulaziz Ahmed M Alqahtani et al., Multidisciplinary Approach Between Emergency – Nurse – Physiotherapy And Medicine For Diabetes Management And The Keys To Preventing Long-Term Consequences And Complications.,Indo Am. J. P. Sci, 2024; 11 (12).

Number of Downloads : 10

References:

1. World Health Organization. (n.d.). Diabetes. Retrieved October 11, 2023, from https://www.who.int/health-topics/diabetes#tab=tab_1
2. World Health Organization. (n.d.). Diabetes. Retrieved October 11, 2023, from https://www.who.int/news-room/fact-sheets/detail/diabetes
3. Shoback D G, & Gardner D (Eds.) (2011). Chapter 17. In Greenspan’s basic & clinical endocrinology (9th ed., pp. 259-284). McGraw-Hill Medical.
4. Kumar V, Abbas A, & Aster J (2021). Chapter 22: Diseases of the Endocrine System. In Robbins & Cotran pathologic basis of disease (10th ed., pp. 1065-1132). Elsevier.
5. Petzold A, Solimena M, & Knoch K P (2015). Mechanisms of Beta Cell Dysfunction Associated With Viral Infection. Current diabetes reports, 15(10), 73.
6. Cleveland Clinic. (n.d.). Diabetes. Retrieved October 11, 2023, from https://my.clevelandclinic.org/health/diseases/7104-diabetes
7. World Health Organization. (1999). Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications (PDF). Retrieved March 8, 2003, from [Original URL removed]
8. Penman I, Ralston S, Strachan M, & Hobson R (2023). Chapter 15: Endocrine disorders. In Davidson’s principles and practice of medicine (24th ed., pp. 703-753). Elsevier.
9. Dhatariya K K, & Joint British Diabetes Societies for Inpatient Care (2022). The management of diabetic ketoacidosis in adults-An updated guideline from the Joint British Diabetes Society for Inpatient Care. Diabetic medicine : a journal of the British Diabetic Association, 39(6), e14788.
10. Willix C, Griffiths E, & Singleton S (2019). Hyperglycaemic presentations in type 2 diabetes. Australian journal of general practice, 48(5), 263–267.
11. Mustafa O G, Haq M, Dashora U, Castro E, Dhatariya K K, & Joint British Diabetes Societies (JBDS) for Inpatient Care Group (2023). Management of Hyperosmolar Hyperglycaemic State (HHS) in Adults: An updated guideline from the Joint British Diabetes Societies (JBDS) for Inpatient Care Group. Diabetic medicine : a journal of the British Diabetic Association, 40(3), e15005.
12. Zahed K, Sasangohar F, Mehta R, Erraguntla M, & Qaraqe K (2020). Diabetes Management Experience and the State of Hypoglycemia: National Online Survey Study. JMIR diabetes, 5(2), e17890.
13. Amiel S A (2021). The consequences of hypoglycaemia. Diabetologia, 64(5), 963–970.
14. Wang W, & Lo A C Y (2018). Diabetic Retinopathy: Pathophysiology and Treatments. International journal of molecular sciences, 19(6), 1816.
15. Samsu N. (2021). Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment. BioMed research international, 2021, 1497449.
16. Panchapakesan, U., & Pollock, C. (2015). The Role of Dipeptidyl Peptidase – 4 Inhibitors in Diabetic Kidney Disease. Frontiers in immunology, 6, 443.
17. Kim M K (2017). Treatment of diabetic kidney disease: current and future targets. The Korean journal of internal medicine, 32(4), 622–630.
18. Pérez-Morales R E, Del Pino M D, Valdivielso J M, Ortiz A, Mora-Fernández C, & Navarro-González J F (2019). Inflammation in Diabetic Kidney Disease. Nephron, 143(1), 12–16.
19. Feldman E L, Callaghan B C, Pop-Busui R, Zochodne D W, Wright D E, Bennett D L, Bril V, Russell J W, & Viswanathan V (2019). Diabetic neuropathy. Nature reviews. Disease primers, 5(1), 42.
20. Belenichev I, Aliyeva O, Popazova O, & Bukhtiyarova N (2023). Molecular and biochemical mechanisms of diabetic encephalopathy. Acta biochimica Polonica, 70(4), 751–760.
21. Shi Y S, Chen J C, Lin L, Cheng Y Z, Zhao Y, Zhang Y, & Pan X D (2023). Dendrobine rescues cognitive dysfunction in diabetic encephalopathy by inhibiting ferroptosis via activating Nrf2/GPX4 axis. Phytomedicine : international journal of phytotherapy and phytopharmacology, 119, 154993.
22. Lorenzo-Almorós A, Cepeda-Rodrigo J M, & Lorenzo Ó. (2022). Diabetic cardiomyopathy. Revista clinica espanola, 222(2), 100–111.
23. Kobayashi S, & Liang Q (2015). Autophagy and mitophagy in diabetic cardiomyopathy. Biochimica et biophysica acta, 1852(2), 252–261.
24. Zhao X, Liu S, Wang X, Chen Y, Pang P, Yang Q, Lin J, Deng S, Wu S, Fan G, & Wang B (2022). Diabetic cardiomyopathy: Clinical phenotype and practice. Frontiers in endocrinology, 13, 1032268.
25. Acharya A B, Thakur S, & Muddapur M V (2015). Evaluation of serum interleukin-10 levels as a predictor of glycemic alteration in chronic periodontitis and type 2 diabetes mellitus. Journal of Indian Society of Periodontology, 19(4), 388–392.
26. Reddy P V, Ambati M, & Koduganti R (2015). Systemic lycopene as an adjunct to scaling and root planing in chronic periodontitis patients with type 2 diabetes mellitus. Journal of International Society of Preventive & Community Dentistry, 5(Suppl 1), S25–S31.
27. Zimmerman R S (2016, September). Diabetes Mellitus: Management of Microvascular and Macrovascular Complications. Cleveland Clinic Center for Continuing Education. Retrieved December 13, 2024
28. Shen Y, Wang T, Gao M, Wang F, Zhu X, Zhang X, Li D, Gan Y, Zhang Y, Gao Y, & Sun X (2020). Association of glucose control and stages of change for multiple self-management behaviors in patients with diabetes: A latent profile analysis. Patient education d counseling, 103(1), 214–219.
29. Lin H C, Tseng C W, Hsieh P J, Liang H L, Sue S P, Huang C Y, & Lee M Y (2022). Efficacy of Self-Management on Glucose Control in Type 2 Diabetes Mellitus Patients Treated with Insulin. Healthcare (Basel, Switzerland), 10(10), 2080.
30. Rawlins W S, Toscano-Garand M A, & Graham G (2017). Diabetes management with a care coordinator improves glucose control in African Americans and Hispanics. Journal of education and health promotion, 6, 22.
31. McDermott M. (2022). Diabetes Secrets. Elsevier. pp. 52–54. ISBN 978-0-323-79262-2.
32. Care D. (2023). Standards of care in diabetes—2023. Diabetes care, 46, S1-S267.
33. McDermott M T, & Trujillo J M (2022). Diabetes secrets. Elsevier.
34. American Diabetes Association. (n.d.). Practice Guidelines Resources. Retrieved July 12, 2023, from https://professional.diabetes.org/standards-of-care/practice-guidelines-resources
35. Chao A M, Tronieri J S, Amaro A, & Wadden T A (2023). Semaglutide for the treatment of obesity. Trends in cardiovascular medicine, 33(3), 159–166.
36. Almurashi A M, Rodriguez E, & Garg S K (2023). Emerging Diabetes Technologies: Continuous Glucose Monitors/Artificial Pancreases. Journal of the Indian Institute of Science, 1–26. Advance online publication.
37. Ooba N, Tanaka S, Yasukawa Y, Yoshino N, Hayashi H, Hidaka S, Seki T, & Fukuoka N (2016). Effect of high-potency statins on HbA1c in patients with or without diabetes mellitus. Journal of pharmaceutical health care and sciences, 2, 8.
38. Cheng J, Zhang W, Zhang X, Han F, Li X, He X, Li Q, & Chen J (2014). Effect of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis. JAMA internal medicine, 174(5), 773–785.
39. I., Z., Samosiuk., O, Vladimirov., O, Chukhraeva., V, Maikovets., N., I., Samosiuk., Anna, Nalazek., Walery, Zukow. (2011). Modern physiotherapy methods in medical rehabilitation of patients with diabetes mellitus type 2. Journal of Health Science, 1(4):101-124.
40. Aline, A., Gomes., Cristina, D., Sartor., Sílvia, Maria, Amado, João., Isabel, C., N., Sacco., Marcia, Martins, Silveira, Bernik. (2007). Efeitos da intervenção fisioterapêutica nas respostas sensoriais e funcionais de diabéticos neuropatas. Fisioterapia e Pesquisa, 14(1):14-21. doi: 10.1590/FPUSP.V14I1.75500